Responses to parliamentary questions
Question from Deputy David Cullinane - PQ 10724-26
Deputy Cullinane asked why pluvicto was not approved for reimbursement but luthathera received approval. Read the HSE response.
From: Communications and public affairs
Published: February 2026
Updated: February 2026
Documents
Question from Deputy David Cullinane - PQ 10724-26
PDF, 454KB, 3 pages
Summary
To ask the Minister for Health the reason pluvicto was not approved for reimbursement but luthathera received approval; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it